Literature DB >> 21645591

Positive emotional learning is regulated in the medial prefrontal cortex by GluN2B-containing NMDA receptors.

J Burgdorf1, R A Kroes, C Weiss, M M Oh, J F Disterhoft, S M Brudzynski, J Panksepp, J R Moskal.   

Abstract

In rats, hedonic ultrasonic vocalizations (USVs) is a validated model of positive affect and is best elicited by rough-and-tumble play. Here we report that modulation of GluN2B-containing NMDA receptors (NMDAR) in the medial prefrontal cortex (MPFC) is involved in positive emotional learning. Rough and tumble play increased both GluN1 and GluN2B NMDAR subunit mRNA and protein levels in the frontal cortex. GLYX-13, a GluN2B-preferring, NMDAR glycine-site partial agonist (1 mg/kg, i.v.) significantly increased positive emotional learning whereas the GluN2B receptor-specific antagonist, ifenprodil (10 mg/kg, i.p.), inhibited positive emotional learning. Animals selectively bred for low rates of hedonic USVs were returned to wild-type levels of positive emotional learning following GLYX-13 treatment. MPFC microinjections of GLYX-13 (0.1-10 μg/side) significantly increased rates of positive emotional learning. Thus GluN2B-containing NMDARs may be involved in positive emotional learning in the MPFC by similar mechanisms as spatial/temporal learning in the hippocampus.
Copyright © 2011 IBRO. Published by Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21645591      PMCID: PMC3166413          DOI: 10.1016/j.neuroscience.2011.05.001

Source DB:  PubMed          Journal:  Neuroscience        ISSN: 0306-4522            Impact factor:   3.590


  40 in total

1.  Anticipation of increasing monetary reward selectively recruits nucleus accumbens.

Authors:  B Knutson; C M Adams; G W Fong; D Hommer
Journal:  J Neurosci       Date:  2001-08-15       Impact factor: 6.167

2.  MK-801 disrupts acquisition of contextual fear conditioning but enhances memory consolidation of cued fear conditioning.

Authors:  T J Gould; M M McCarthy; R A Keith
Journal:  Behav Pharmacol       Date:  2002-07       Impact factor: 2.293

3.  Amplified RNA synthesized from limited quantities of heterogeneous cDNA.

Authors:  R N Van Gelder; M E von Zastrow; A Yool; W C Dement; J D Barchas; J H Eberwine
Journal:  Proc Natl Acad Sci U S A       Date:  1990-03       Impact factor: 11.205

4.  Acquisition of fear extinction requires activation of NR2B-containing NMDA receptors in the lateral amygdala.

Authors:  Francisco Sotres-Bayon; David E A Bush; Joseph E LeDoux
Journal:  Neuropsychopharmacology       Date:  2007-01-10       Impact factor: 7.853

5.  Neurobiology of 50-kHz ultrasonic vocalizations in rats: electrode mapping, lesion, and pharmacology studies.

Authors:  Jeffrey Burgdorf; Paul L Wood; Roger A Kroes; Joseph R Moskal; Jaak Panksepp
Journal:  Behav Brain Res       Date:  2007-03-19       Impact factor: 3.332

6.  NMDA receptor hypofunction produces opposite effects on prefrontal cortex interneurons and pyramidal neurons.

Authors:  Houman Homayoun; Bita Moghaddam
Journal:  J Neurosci       Date:  2007-10-24       Impact factor: 6.167

7.  Regional brain cholecystokinin changes as a function of rough-and-tumble play behavior in adolescent rats.

Authors:  Jeffrey Burgdorf; Jaak Panksepp; Margery C Beinfeld; Roger A Kroes; Joseph R Moskal
Journal:  Peptides       Date:  2005-09-06       Impact factor: 3.750

8.  GLYX-13: a monoclonal antibody-derived peptide that acts as an N-methyl-D-aspartate receptor modulator.

Authors:  Joseph R Moskal; Amy G Kuo; Craig Weiss; Paul L Wood; Amy O'Connor Hanson; Stephen Kelso; Robert B Harris; John F Disterhoft
Journal:  Neuropharmacology       Date:  2005-07-26       Impact factor: 5.250

9.  Facilitation of conditioned fear extinction by systemic administration or intra-amygdala infusions of D-cycloserine as assessed with fear-potentiated startle in rats.

Authors:  David L Walker; Kerry J Ressler; Kwok-Tung Lu; Michael Davis
Journal:  J Neurosci       Date:  2002-03-15       Impact factor: 6.167

10.  Hippocampus-dependent learning facilitated by a monoclonal antibody or D-cycloserine.

Authors:  L T Thompson; J R Moskal; J F Disterhoft
Journal:  Nature       Date:  1992-10-15       Impact factor: 49.962

View more
  26 in total

1.  Increasing SK2 channel activity impairs associative learning.

Authors:  Bridget M McKay; M Matthew Oh; Roberto Galvez; Jeffrey Burgdorf; Roger A Kroes; Craig Weiss; John P Adelman; Joseph R Moskal; John F Disterhoft
Journal:  J Neurophysiol       Date:  2012-05-02       Impact factor: 2.714

Review 2.  Rats selectively bred for low levels of play-induced 50 kHz vocalizations as a model for autism spectrum disorders: a role for NMDA receptors.

Authors:  Jeffrey Burgdorf; Joseph R Moskal; Stefan M Brudzynski; Jaak Panksepp
Journal:  Behav Brain Res       Date:  2013-04-23       Impact factor: 3.332

Review 3.  Integrative biological analysis for neuropsychopharmacology.

Authors:  Mark R Emmett; Roger A Kroes; Joseph R Moskal; Charles A Conrad; Waldemar Priebe; Fernanda Laezza; Anke Meyer-Baese; Carol L Nilsson
Journal:  Neuropsychopharmacology       Date:  2013-06-26       Impact factor: 7.853

4.  The effects of long-term estradiol treatment on social behavior and gene expression in adult female rats.

Authors:  Alexandra N Garcia; Kelsey Bezner; Christina Depena; Weiling Yin; Andrea C Gore
Journal:  Horm Behav       Date:  2016-11-19       Impact factor: 3.587

Review 5.  GLYX-13, an NMDA receptor glycine site functional partial agonist enhances cognition and produces antidepressant effects without the psychotomimetic side effects of NMDA receptor antagonists.

Authors:  Joseph R Moskal; Ronald Burch; Jeffrey S Burgdorf; Roger A Kroes; Patric K Stanton; John F Disterhoft; J David Leander
Journal:  Expert Opin Investig Drugs       Date:  2013-11-20       Impact factor: 6.206

Review 6.  NMDA receptor modulators: an updated patent review (2013-2014).

Authors:  Katie L Strong; Yao Jing; Anthony R Prosser; Stephen F Traynelis; Dennis C Liotta
Journal:  Expert Opin Ther Pat       Date:  2014-10-29       Impact factor: 6.674

7.  Late adolescent expression of GluN2B transmission in the prefrontal cortex is input-specific and requires postsynaptic protein kinase A and D1 dopamine receptor signaling.

Authors:  Eden Flores-Barrera; Daniel R Thomases; Li-Jun Heng; Daryn K Cass; Adriana Caballero; Kuei Y Tseng
Journal:  Biol Psychiatry       Date:  2013-09-13       Impact factor: 13.382

8.  Individual differences in the conditioned and unconditioned rat 50-kHz ultrasonic vocalizations elicited by repeated amphetamine exposure.

Authors:  Allison M Ahrens; Cameron W Nobile; Lindsay E Page; Esther Y Maier; Christine L Duvauchelle; Timothy Schallert
Journal:  Psychopharmacology (Berl)       Date:  2013-05-23       Impact factor: 4.530

9.  Rapastinel (GLYX-13) has therapeutic potential for the treatment of post-traumatic stress disorder: Characterization of a NMDA receptor-mediated metaplasticity process in the medial prefrontal cortex of rats.

Authors:  Jeffrey Burgdorf; Roger A Kroes; Xiao-lei Zhang; Amanda L Gross; Mary Schmidt; Craig Weiss; John F Disterhoft; Ronald M Burch; Patric K Stanton; Joseph R Moskal
Journal:  Behav Brain Res       Date:  2015-07-22       Impact factor: 3.332

10.  GLYX-13 (rapastinel) ameliorates subchronic phencyclidine- and ketamine-induced declarative memory deficits in mice.

Authors:  Lakshmi Rajagopal; Jeffrey S Burgdorf; Joseph R Moskal; Herbert Y Meltzer
Journal:  Behav Brain Res       Date:  2015-11-26       Impact factor: 3.332

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.